Clin Endosc.  2018 Mar;51(2):111-112. 10.5946/ce.2018.037.

Retention Esophagitis in Patients with Achalasia Requires Cancer Surveillance

Affiliations
  • 1Department of Internal Medicine, Gangneung Asan Hospital, Gangneung, Korea.
  • 2Department of Gastroenterology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea. dohoon.md@gmail.com

Abstract

No abstract available.


MeSH Terms

Esophageal Achalasia*
Esophagitis*
Humans

Reference

1. Sadowski DC, Ackah F, Jiang B, Svenson LW. Achalasia: incidence, prevalence and survival. A population-based study. Neurogastroenterol Motil. 2010; 22:e256–e261.
Article
2. Meijssen MA, Tilanus HW, van Blankenstein M, Hop WC, Ong GL. Achalasia complicated by oesophageal squamous cell carcinoma: a prospective study in 195 patients. Gut. 1992; 33:155–158.
Article
3. Leeuwenburgh I, Scholten P, Alderliesten J, et al. Long-term esophageal cancer risk in patients with primary achalasia: a prospective study. Am J Gastroenterol. 2010; 105:2144–2149.
Article
4. Streitz JM Jr, Ellis FH Jr, Gibb SP, Heatley GM. Achalasia and squamous cell carcinoma of the esophagus: analysis of 241 patients. Ann Thorac Surg. 1995; 59:1604–1609.
Article
5. Chino O, Kijima H, Shimada H, et al. Clinicopathological studies of esophageal carcinoma in achalasia: analyses of carcinogenesis using histological and immunohistochemical procedures. Anticancer Res. 2000; 20:3717–3722.
6. Hirota WK, Zuckerman MJ, Adler DG, et al. ASGE guideline: the role of endoscopy in the surveillance of premalignant conditions of the upper GI tract. Gastrointest Endosc. 2006; 63:570–580.
Article
7. Vaezi MF, Pandolfino JE, Vela MF. ACG clinical guideline: diagnosis and management of achalasia. Am J Gastroenterol. 2013; 108:1238–1249. quiz 1250.
Article
8. Eckardt VF, Hoischen T, Bernhard G. Life expectancy, complications, and causes of death in patients with achalasia: results of a 33-year follow-up investigation. Eur J Gastroenterol Hepatol. 2008; 20:956–960.
Article
9. Loviscek LF, Cenoz MC, Badaloni AE, Agarinakazato O. Early cancer in achalasia. Dis Esophagus. 1998; 11:239–247.
Article
10. Kim H, Park H, Choi HS, et al. Retention esophagitis as a significant clinical predictor of progression to esophageal cancer in achalasia. Clin Endosc. 2018; 51:161–166.
Article
11. Leeuwenburgh I, Gerrits MM, Capello A, et al. Expression of p53 as predictor for the development of esophageal cancer in achalasia patients. Dis Esophagus. 2010; 23:506–511.
12. Fujii T, Yamana H, Sueyoshi S, et al. Histopathological analysis of non-malignant and malignant epithelium in achalasia of the esophagus. Dis Esophagus. 2000; 13:110–116.
Article
13. Inoue H, Minami H, Kobayashi Y, et al. Peroral endoscopic myotomy (POEM) for esophageal achalasia. Endoscopy. 2010; 42:265–271.
Article
14. Minami H, Yamaguchi N, Matsushima K, et al. Improvement of endocytoscopic findings after per oral endoscopic myotomy (POEM) in esophageal achalasia; does POEM reduce the risk of developing esophageal carcinoma? Per oral endoscopic myotomy, endocytoscopy and carcinogenesis. BMC Gastroenterol. 2013; 13:22.
Article
15. Leeuwenburgh I, Van Dekken H, Scholten P, et al. Oesophagitis is common in patients with achalasia after pneumatic dilatation. Aliment Pharmacol Ther. 2006; 23:1197–1203.
Article
16. Ota M, Narumiya K, Kudo K, et al. Incidence of esophageal carcinomas after surgery for achalasia: usefulness of long-term and periodic follow-up. Am J Case Rep. 2016; 17:845–849.
Article
Full Text Links
  • CE
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr